Results 181 to 189 of about 8,165 (189)

Febuxostat suppressed renal ischemia–reperfusion injury via reduced oxidative stress

Biochemical and Biophysical Research Communications, 2012
Hiromi Rakugi, Yoshitaka Isaka, Jun-Ya Kaimori   +2 more
exaly  

Febuxostat

Reactions Weekly, 2023
openaire   +1 more source

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

New England Journal of Medicine, 2005
exaly  

Febuxostat: A Review of Its Use in the Treatment of Hyperuricaemia in Patients with Gout

Drugs, 2015
exaly  

Summary of opinion: Febuxostat Krka,febuxostat

Case Medical Research, 2019
openaire   +1 more source

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

Life Sciences, 2005
exaly  

Febuxostat versus Allopurinol for Gout

New England Journal of Medicine, 2006
exaly  

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

Rheumatology, 2009
exaly  

FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

Annals of Oncology, 2015
exaly